Thyroid cancer is a common endocrine malignancy. There has been exciting progress in
understanding its molecular pathogenesis in recent years, as best exemplified by the …

Thyroid cancer is a common type of endocrine malignancy, and its incidence has been
steadily increasing in many regions of the world. Initiation and progression of thyroid cancer …

The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the
management of different types of thyroid carcinoma, including papillary, follicular, Hürthle …

BACKGROUND Fine‐needle aspiration (FNA) cytology is a common approach to evaluating
thyroid nodules, although 20% to 30% of FNAs have indeterminate cytology, which hampers …

Substantial developments have occurred in the past 5–10 years in clinical translational
research of thyroid cancer. Diagnostic molecular markers, such as RET-PTC, RAS, and …

Background: The benefits of prophylactic central compartment lymph node dissection
(pCCND) in papillary thyroid cancer (PTC) are still under investigation. This treatment seems …

Background: There is conflicting literature regarding the association of the BRAF V600E
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …

Introduction Over the past years, the incidence of thyroid cancer has surged not only in
Germany but also in other countries of the Western hemisphere. This surge was first and …

Abstract Context: Thyroglobulin autoantibodies (TgAb) are primarily measured in serum in
conjunction with thyroglobulin (Tg)—the primary tumor marker used to monitor patients with …

Context.—Thyroid cancer is the most common type of endocrine malignancy and its
incidence is steadily increasing. Papillary carcinoma and follicular carcinoma are the most …